Alvotech And Reddy’s Await US Denosumab Decision As Launch Date Closes In
Icelandic Firm’s AVT03 Rival Accepted For Review; Fresenius Kabi Just Settled Litigation
With Sandoz set to debut US competition to Prolia and Xgeva in a matter of months, other biosimilar sponsors are working hard to ensure launch of Amgen’s blockbuster in a timely manner.
